Brady Family Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,831
Closed -$343K 115
2025
Q2
$343K Hold
2,831
0.11% 90
2025
Q1
$316K Hold
2,831
0.1% 95
2024
Q4
$275K Sell
2,831
-429
-13% -$45.7K 0.08% 99
2024
Q3
$375K Hold
3,260
0.11% 95
2024
Q2
$347K Hold
3,260
0.11% 95
2024
Q1
$315K Hold
3,260
0.1% 101
2023
Q4
$329K Sell
3,260
-110
-3% -$10.6K 0.11% 97
2023
Q3
$343K Buy
3,370
+110
+3% +$11.2K 0.13% 93
2023
Q2
$329K Hold
3,260
0.12% 97
2023
Q1
$300K Buy
3,260
+550
+20% +$48K 0.12% 101
2022
Q4
$246K Buy
+2,710
New +$228K 0.1% 107

Other funds holding NVS

Brady Family Wealth's NVS Position: Q3 2025 in Review

Brady Family Wealth sold out of Novartis (NVS) in Q3 2025, closing a stake of 2,831 shares — an estimated $343K sold.

Brady Family Wealth first reported a position in NVS in Q4 2022 and held it in 11 quarters. The position peaked at $375K in Q3 2024. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Brady Family Wealth reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Brady Family Wealth sold 2,831 Novartis shares in Q3 2025, an estimated $343K.
  • Brady Family Wealth first reported a position in Novartis in Q4 2022 and held it in 11 quarters.
  • Brady Family Wealth's Novartis position peaked at $375K in Q3 2024.
  • 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Brady Family Wealth's 13F filing for Q3 2025, filed 9 Oct 2025.